Skip to main content

Advertisement

Log in

Preparation and Transformation of Solid Glass Solutions of Clotrimazole to Nanosuspensions with Improved Physicochemical and Antifungal Properties

  • Original Article
  • Published:
Journal of Pharmaceutical Innovation Aims and scope Submit manuscript

Abstract

Purpose

Evaluating the feasibility of two-step preparation of clotrimazole solid glass solutions for improving its physicochemical properties, intrinsic dissolution, and antifungal activity.

Methods

Co-grinding with selected coformers including vitamin C and L-arginine was employed to form co-amorphous dispersions; then, a polymeric carrier was added to form a homogenous glass solution. The solid solutions were converted to nanosuspensions after reconstitution and ultrasonication. The dispersions were characterized for equilibrium solubility, intrinsic dissolution, particle size, and zeta potential. Solid state characterization was carried out using differential scanning calorimetry, X-ray powder diffraction, and Infrared spectroscopy. The antifungal activity was evaluated using candida albicans species.

Results

Equilibrium solubility indicated superb increase in clotrimazole solubility (more than 289 times) from glass solutions compared to pure crystalline drug. The intrinsic dissolution data showed 64% ± 0.34 of drug released within 15 min, and complete dissolution was obtained in 45 min. The ideal formula showed nanosized particles after dispersion in water (225 nm), optimum zeta potential (20.20 µV), and polydispersity index (0.35). Solid state characterization showed shortened peaks and diffraction lines of the glass solutions compared to parent components. The biological activity of the reconstituted nanosuspension showed decreased minimum inhibitory concentration by 50% and increased area of growth inhibition zones of candida albicans by more than 28% compared to drug solution.

Conclusions

These findings suggest that solid glass solutions and its derived nanosuspensions of clotrimazole with ascorbic acid and polyvinyl pyrrolidone could be a valuable solution for maximizing drug bioavailability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12
Fig. 13

Similar content being viewed by others

References

  1. Wouters OJ, McKee M, Luyten J. Estimated research and development investment needed to bring a new medicine to market 2009–2018. JAMA. 2020;323:844–53.

    Article  Google Scholar 

  2. Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today. 2007;12:1068–75.

    Article  CAS  Google Scholar 

  3. Ali A, Abdelhaleem M, Ali AA, Maghrabi IA. Clozapine-carboxylic acid plasticized co-amorphous dispersions: preparation, characterization and solution stability evaluation. Acta Pharm. 2015;65:133–46.

  4. Karagianni A, Kachrimanis K, Nikolakakis I. Co-amorphous solid dispersions for solubility and absorption improvement of drugs: composition, preparation, characterization and formulations for oral delivery. Pharmaceutics. 2018;10:98.

    Article  CAS  Google Scholar 

  5. Rane Y, Mashru R, Sankalia M, Sankalia J. Effect of hydrophilic swellable polymers on dissolution enhancement of carbamazepine solid dispersions studied using response surface methodology. AAPS PharmSciTech. 2007;8:E1–11.

    Article  Google Scholar 

  6. Ali AM, Khames A, Alrobaian MM, Hamaidi M, Abourehab MA. Glucosamine-paracetamol spray-dried solid dispersions with maximized intrinsic dissolution rate, bioavailability and decreased levels of in vivo toxic metabolites. Drug Des Devel Ther 2018;12:3071–84.  https://doi.org/10.2147/DDDT.S176099.

  7. Newman A, Reutzel-Edens SM, Zografi G. Coamorphous active pharmaceutical ingredient–small molecule mixtures: considerations in the choice of coformers for enhancing dissolution and oral bioavailability. J Pharm Sci. 2018;107:5–17.

    Article  CAS  Google Scholar 

  8. Balata G, Mahdi M, Bakera RA. Improvement of solubility and dissolution properties of clotrimazole by solid dispersions and inclusion complexes. Indian J Pharm Sci. 2011;73:517.

    Article  Google Scholar 

  9. Madgulkar A, Bandivadekar M, Shid T, Rao S. Sugars as solid dispersion carrier to improve solubility and dissolution of the BCS class II drug: clotrimazole. Drug Dev Ind Pharm. 2016;42:28–38.

    Article  CAS  Google Scholar 

  10. Verma P, Ahuja M. Optimization, characterization and evaluation of chitosan-tailored cubic nanoparticles of clotrimazole. Int J Biol Macromol. 2015;73:138–45.  https://doi.org/10.1016/j.ijbiomac.2014.10.065.

  11. Carbone C, Teixeira MD, Sousa MD, Martins-Gomes C, Silva AM, Souto EM, Musumeci T. Clotrimazole-loaded Mediterranean essential oils NLC: a synergic treatment of Candida skin infections. Pharmaceut. 2019;11: 231.

  12. Dengale SJ, Grohganz H, Rades T, Löbmann K. Recent advances in co-amorphous drug formulations. Adv Drug Deliv Rev. 2016;100:116–25.

    Article  CAS  Google Scholar 

  13. Dereymaker A, Scurr DJ, Steer ED, Roberts CJ, Van den Mooter G. Controlling the release of indomethacin from glass solutions layered with a rate controlling membrane using fluid-bed processing. Part 1: surface and cross-sectional chemical analysis. Mol Pharm. 2017;14:959–73.

  14. Andrews GP, Abu-Diak O, Kusmanto F, Hornsby P, Hui Z, Jones DS. Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions. J Pharm Pharmacol. 2010;62:1580–90.

    Article  CAS  Google Scholar 

  15. Srinarong P, de Waard H, Frijlink HW, Hinrichs WLJ. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations. Expert Opin Drug Deliv. 2011;8:1121–40.

    Article  CAS  Google Scholar 

  16. Hájková R, Sklenářová H, Matysová L, Švecová P, Solich P. Development and validation of HPLC method for determination of clotrimazole and its two degradation products in spray formulation. Talanta. 2007;73:483–89. https://doi.org/10.1016/j.talanta.2007.04.023.

  17. Abdelbary AA, Al-Mahallawi AM, Abdelrahim ME, Ali AMA. Preparation, optimization, and in vitro simulated inhalation delivery of carvedilol nanoparticles loaded on a coarse carrier intended for pulmonary administration. Int J Nanomedicine. 2015;10:6339.

    Article  CAS  Google Scholar 

  18. Maher EM, Ali AMA, Salem HF, Abdelrahman AA. In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids. Drug Deliv. 2016;23:3088–100.

    Article  CAS  Google Scholar 

  19. Ali AM, Al-Remawi MM. Freeze dried quetiapine-nicotinamide binary solid dispersions: a new strategy for improving physicochemical properties and ex vivo diffusion. J Pharm. 2016;2016.

  20. Yu LX, Carlin AS, Amidon GL, Hussain AS. Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs. Int J Pharm. 2004;270:221–7.

    Article  CAS  Google Scholar 

  21. Seeley Jr HW, Van Demark PJ. Microbes in action. A laboratory manual of microbiology. 2nd ed. D B. Taraporewala Sons and Co. Bombay. 1975.

  22. Ahmed SH, Amin MA, Saafan AE, El-Gendy AO, El-Gendy AO, Islam M. Measuring susceptibility of Candida albicans biofilms towards antifungal agents. Der Pharm Lett. 2013;5:376–83.

    CAS  Google Scholar 

  23. El-Gendy AO, Essam TM, Amin MA, Ahmed SH, Nes IF. Clinical screening for bacteriocinogenic Enterococcus faecalis isolated from intensive care unit inpatient in Egypt. J Microb Biochem Technol. 2013;4:161–7.

    Google Scholar 

  24. Tarek N, Hassan HM, AbdelGhani SMM, Radwan IA, Hammouda O, El-Gendy AO. Comparative chemical and antimicrobial study of nine essential oils obtained from medicinal plants growing in Egypt. Beni-Suef Univ J Basic Appl Sci. 2014;3:149–56.

    Google Scholar 

  25. Grimling B, Karolewicz B, Nawrot U, Włodarczyk K, Górniak A. Physicochemical and antifungal properties of clotrimazole in combination with high-molecular weight chitosan as a multifunctional excipient. Mar Drugs. 2020;18:591.

    Article  CAS  Google Scholar 

  26. Mura P, Bettinetti GP, Cirri M, Maestrelli F, Sorrenti M, Catenacci L. Solid-state characterization and dissolution properties of naproxen–arginine–hydroxypropyl-β-cyclodextrin ternary system. Eur J Pharm Biopharm. 2005;59:99–106.

    Article  CAS  Google Scholar 

  27. Le Minh T. Designing crystallization based-enantiomeric separation for chiral compound-forming systems in consideration of polymorphism and solvate formation. Doctoral dissertation, Dr. Hut München. 2014.

  28. Anand D, Dhoke GV, Gehrmann J, Garakani TM, Davari MD, Bocola M, Zhu L, Schwaneberg U. Chiral separation of d/l-arginine with whole cells through an engineered fhua nanochannel. Chem Commun. 2019;55:5431–4.

    Article  CAS  Google Scholar 

  29. Tyagi PK, Tyagi S, Gola D, Arya A, Ayatollahi SA, Alshehri MM, Sharifi-Rad J. Ascorbic acid and polyphenols mediated green synthesis of silver nanoparticles from Tagetes erecta L. Aqueous leaf extract and studied their antioxidant properties. J Nanomater 2021;2021.

  30. Mallik T, Kar T. Synthesis, growth and characterization of a new nonlinear optical crystal: L-arginine maleate dihydrate. Cryst Res Technol: J Exp Ind Crystallogr. 2005;40:778–81.

  31. Hani U, Krishna G, Shivakumar HG. Design and optimization of clotrimazole–hydroxypropyl-β-cyclodextrin bioadhesive vaginal tablets using Anacardium occidentale gum by 3 2 factorial design. RSC Adv. 2015;5:35391–404.

    Article  CAS  Google Scholar 

  32. Dong L, Mai Y, Liu Q, Zhang W, Yang J. Mechanism and improved dissolution of glycyrrhetinic acid solid dispersion by alkalizers. Pharmaceutics. 2020;12:82.

    Article  CAS  Google Scholar 

  33. Balata G, Mahdi M, Bakera RA. Improvement of solubility and dissolution properties of clotrimazole by solid dispersions and inclusion complexes. India J Pharm Sci. 2011;73:517–26.

  34. Karolewicz B, Gajda M, Owczarek A, Pluta J, Górniak A. Physicochemical characterization and dissolution studies of solid dispersions of clotrimazole with pluronic F127. Tropical J Pharm Res. 2014;13:1225–32.

    Article  CAS  Google Scholar 

  35. Vasconcelos T, Marques S, das Neves J, Sarmento B. Amorphous solid dispersions: rational selection of a manufacturing process. Adv Drug Deliv Rev. 2016;100:85–101.

  36. Laitinen R, Löbmann K, Grohganz H, Priemel P, Strachan CJ, Rades T. Supersaturating drug delivery systems: the potential of co-amorphous drug formulations. Int J Pharm. 2017;532:1–12.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors of this research would like to acknowledge the financial support offered by Taif University Researchers Supporting Project number (TURSP-2020/50), Taif University, Taif, Saudi Arabia. The authors would also like to thank the Deanship of Scientific Research at Umm Al-Qura University for supporting this work by Grant: 19-MED-1-01-0024 to Mohammed A.S. Abourehab.

Funding

The authors of this research received financial support offered by Taif University Researchers Supporting Project number (TURSP-2020/50), Taif University, Taif, Saudi Arabia.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmed M. Abdelhaleem Ali.

Ethics declarations

Conflict of interest

The authors declare no competing interests. 

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ali, A.M.A., Warsi, M.H., Abourehab, M.A.S. et al. Preparation and Transformation of Solid Glass Solutions of Clotrimazole to Nanosuspensions with Improved Physicochemical and Antifungal Properties. J Pharm Innov 17, 1420–1433 (2022). https://doi.org/10.1007/s12247-021-09595-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12247-021-09595-w

Keywords

Navigation